May 22, 2023, SpringWorks Therapeutics Inc. (NASDAQ: SWTX) trading session started at the price of $30.87, that was 7.28% jump from the session before. During the day, the shares moved up to $33.46 and dropped to $30.675 before settling in for the closing price of $30.49. A 52-week range for SWTX has been $13.60 – $39.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -45.20%. With a float of $54.22 million, this company’s outstanding shares have now reached $62.33 million.
The firm has a total of 227 workers. Let’s measure their productivity.
SpringWorks Therapeutics Inc. (SWTX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc. stocks. The insider ownership of SpringWorks Therapeutics Inc. is 0.50%, while institutional ownership is 106.93%. The most recent insider transaction that took place on Mar 16, was worth 49,875,000. In this transaction Director of this company sold 1,750,000 shares at a rate of $28.50, taking the stock ownership to the 3,081,307 shares. Before that another transaction happened on Mar 15, when Company’s Director sold 1,106 for $31.50, making the entire transaction worth $34,841. This insider now owns 4,818 shares in total.
SpringWorks Therapeutics Inc. (SWTX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$1.18 earnings per share (EPS) during the time that was better than consensus figure (set at -$1.25) by $0.07. This company achieved a return on equity of -56.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -45.20% per share during the next fiscal year.
SpringWorks Therapeutics Inc. (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc. (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.14, a number that is poised to hit -1.26 in the next quarter and is forecasted to reach -4.21 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc. (SWTX)
Analysing the last 5-days average volume posted by the [SpringWorks Therapeutics Inc., SWTX], we can find that recorded value of 0.61 million was lower than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 78.06%. Additionally, its Average True Range was 1.65.
During the past 100 days, SpringWorks Therapeutics Inc.’s (SWTX) raw stochastic average was set at 87.74%, which indicates a significant decrease from 92.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.53% in the past 14 days, which was higher than the 58.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.13, while its 200-day Moving Average is $26.96. Now, the first resistance to watch is $33.89. This is followed by the second major resistance level at $35.07. The third major resistance level sits at $36.67. If the price goes on to break the first support level at $31.10, it is likely to go to the next support level at $29.50. Should the price break the second support level, the third support level stands at $28.32.
SpringWorks Therapeutics Inc. (NASDAQ: SWTX) Key Stats
There are 62,523K outstanding shares of the company, which has a market capitalization of 1.94 billion. As of now, sales total 0 K while income totals -277,420 K. Its latest quarter income was 0 K while its last quarter net income were -73,420 K.
